相关实验视频
Updated: Jul 4, 2025

05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.1K
协同度指数分解:对生存预测模型的更深入理解的一种措施
Abdallah Alabdallah1, Mattias Ohlsson2, Sepideh Pashami3
1Center for Applied Intelligent Systems Research (CAISR), Halmstad University, Sweden.
Artificial intelligence in medicine
|February 7, 2024
概括
我们为生存分析引入了新的协同指数 (C指数) 分解. 这种方法揭示了深度学习模型在排名事件中表现出色,在各种审查级别中表现优于经典方法.
科学领域:
- 生物统计学 生物统计学
- 机器学习 机器学习
- 生存分析的分析.
背景情况:
- 协同指数 (C指数) 是评估生存预测模型的标准度量.
- 现有的方法缺乏对不同数据特征的模型性能的详细理解,例如审查级别.
研究的目的:
- 提出一种新的C指数分解方法,以便对生存预测模型进行更细致的分析.
- 将深度学习模型的性能与经典和最先进的方法进行比较,使用拟议的C指数分解.
主要方法:
- 将C指数分解为两个组成部分的加权和平均值:事件-事件排名和事件审查排名.
- 使用四个具有不同审查级别的公共数据集进行基准测试.
- 介绍和评估一种新的基于变异生成神经网络的方法 (SurVED).
主要成果:
- 包括SurVED在内的深度学习模型展示了对观察到的事件的优越利用,在不同审查级别中保持稳定的C指数表现.
- 经典的机器学习模型显示性能下降,由于事件-事件排名的限制,审查减少.
- C指数分解有效地突出了各种生存预测方法的优缺点.
结论:
- 拟议的C指数分解为生存模型的性能提供了更深入的见解.
- 深度学习模型在处理不同级别的审查方面具有优势,因为它们具有有效的事件排名能力.
- 这项工作有助于选择和开发更强大的生存预测模型.
相关概念视频
Survival Tree
86
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
86
Comparing the Survival Analysis of Two or More Groups
188
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
188
Assumptions of Survival Analysis
128
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
128
Introduction To Survival Analysis
239
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
239
Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
Kaplan-Meier Approach
141
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
141

